303 related articles for article (PubMed ID: 17542899)
1. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
Diluvio L; Campione E; Paternò EJ; Mordenti C; El Hachem M; Chimenti S
Pediatr Dermatol; 2007; 24(3):332-3. PubMed ID: 17542899
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.
Scher RK; Stiller M; Zhu YI
Cutis; 2001 Nov; 68(5):355-8. PubMed ID: 11766122
[TBL] [Abstract][Full Text] [Related]
3. Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment.
Fischer-Levancini C; Sánchez-Regaña M; Llambí F; Collgros H; Expósito-Serrano V; Umbert-Millet P
Actas Dermosifiliogr; 2012 Oct; 103(8):725-8. PubMed ID: 22818395
[TBL] [Abstract][Full Text] [Related]
4. Tacalcitol ointment for the treatment of nail psoriasis.
Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
6. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study.
Bianchi L; Soda R; Diluvio L; Chimenti S
Br J Dermatol; 2003 Jul; 149(1):207-9. PubMed ID: 12890227
[No Abstract] [Full Text] [Related]
7. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
Rigopoulos D; Gregoriou S; Katsambas A
Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
[No Abstract] [Full Text] [Related]
8. Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.
Piraccini BM; Venturi M; Patrizi A
G Ital Dermatol Venereol; 2014 Jun; 149(3):363-6. PubMed ID: 24819765
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of tazarotene action in psoriasis.
Duvic M; Nagpal S; Asano AT; Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
[TBL] [Abstract][Full Text] [Related]
10. A case of nail psoriasis treated with topical calcitriol.
Usmani N; Wilson C
Clin Exp Dermatol; 2006 Sep; 31(5):712-3. PubMed ID: 16901318
[No Abstract] [Full Text] [Related]
11. [Prescribe topical treatments for psoriasis].
Lorette G; Fontès V
Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
Tzung TY; Chen CY; Yang CY; Lo PY; Chen YH
Acta Derm Venereol; 2008; 88(3):279-80. PubMed ID: 18480933
[No Abstract] [Full Text] [Related]
13. Nail psoriasis improvement in a patient treated with fumaric acid esters.
Vlachou C; Berth-Jones J
J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
[TBL] [Abstract][Full Text] [Related]
14. Severe 20-nail psoriasis successfully treated by low dose methotrexate.
Lee JY
Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
16. Oral tazarotene and oral pimecrolimus: novel oral therapies in development for psoriasis.
Singh F; Weinberg JM
J Drugs Dermatol; 2004; 3(2):141-3. PubMed ID: 15098968
[TBL] [Abstract][Full Text] [Related]
17. [Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].
Henno A; Hua MT; de la Brassinne M
Rev Med Liege; 2003 Nov; 58(11):706-8. PubMed ID: 14748200
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic profile of tazarotene.
Duvic M
Cutis; 1998 Feb; 61(2 Suppl):22-6. PubMed ID: 9787988
[TBL] [Abstract][Full Text] [Related]
19. Treatment of occupational koilonychia with tazarotene gel.
Hagman JH; Ginebri A; Mordenti C; De Simoni I; Chimenti S
Acta Derm Venereol; 2003; 83(4):296-7. PubMed ID: 12926806
[No Abstract] [Full Text] [Related]
20. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Jiaravuthisan MM; Sasseville D; Vender RB; Murphy F; Muhn CY
J Am Acad Dermatol; 2007 Jul; 57(1):1-27. PubMed ID: 17572277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
